The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC. | COM | 00287Y109 | 92 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 73,045 | 546,500 | SH | SOLE | 546,500 | 0 | 0 | ||
| BIOGEN INC. | COM | 09062X103 | 138,982 | 461,858 | SH | SOLE | 461,858 | 0 | 0 | ||
| INNOVIVA INC. | COM | 45781M101 | 88,141 | 5,051,100 | SH | SOLE | 5,051,100 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS INC. | COM | 45845P108 | 5,442 | 54,000 | SH | SOLE | 54,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC. | COM CL A | 46333X108 | 64,773 | 6,252,300 | SH | SOLE | 6,252,300 | 0 | 0 | ||
| MEDICINES CO. | COM | 584688105 | 53,228 | 2,781,000 | SH | SOLE | 2,781,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC. | COM | 60468T105 | 42 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC. | COM | 74587V107 | 27,330 | 1,343,000 | SH | SOLE | 1,343,000 | 0 | 0 | ||
| SHIRE PLC | SPONSORED ADR | 82481R106 | 174 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||